m 6A甲基化与肿瘤研究进展

doi:10.16288/j.yczz.18-098

遗传 ›› 2018, Vol. 40 ›› Issue (12): 1055-1065.doi: 10.16288/j.yczz.18-098

• 综述 • 下一篇

m ⁶A甲基化与肿瘤研究进展

王天工¹,叶孟²()

^1. 宁波大学医学院,宁波 315211
^2. 宁波大学医学院附属医院,宁波 315211

收稿日期:2018-05-18 修回日期:2018-07-31 出版日期:2018-12-20 发布日期:2018-09-25
通讯作者: 叶孟 E-mail:ndfy_yemeng@163.com
作者简介:王天工,硕士研究生,专业方向：肿瘤学。E-mail: tonywoolf21@gmail.com
基金资助:
浙江省自然科学基金项目(编号：Y16H160019)资助(Y16H160019)

Advances on the roles of m ⁶A in tumorigenesis

Wang Tiangong¹,Ye Meng²()

^1. Medical School of Ningbo University, Ningbo 315211, China
^2. The Affiliated Hospital of Medical School of Ningbo University, Ningbo 315211, China

Received:2018-05-18 Revised:2018-07-31 Online:2018-12-20 Published:2018-09-25
Contact: Ye Meng E-mail:ndfy_yemeng@163.com
Supported by:
Supported by Zhejiang Provincial Natural Science Foundation of China(Y16H160019)

摘要/Abstract

摘要：

m ⁶A甲基化是20世纪70年代被发现的一种RNA分子上的甲基化修饰,存在于各种RNA中,但主要在mRNA中出现。与DNA甲基化相似,m ⁶A甲基化也可以在不改变碱基序列的情况下对基因的转录后表达水平具有调控作用。它主要是通过影响mRNA与读取蛋白的结合,从而调控mRNA的可变剪接、翻译效率和稳定性等,进而改变基因表达。研究早期,受限于m ⁶A甲基化位点的检测技术不够灵敏,转录组中的m ⁶A位点无法被完整而有效地鉴别。随着二代测序与生物信息学的发展,已有多种方法可以对m ⁶A甲基化位点进行检测和预测。目前的研究表明,m ⁶A甲基化与肿瘤的发生发展也密切相关。本文结合近期的研究进展,对m ⁶A甲基化的概念、检测和预测手段,特别是m6A与肿瘤发生之间的关系进行了综述,旨在为肿瘤的分子病理诊断和分子靶向治疗寻找新方向。

关键词: m ⁶A甲基化, RNA甲基化, 表观遗传, 肿瘤

Abstract:

Predominantly found in mRNA, m ⁶A methylation of RNA molecules regulates post-transcriptional gene expression without changing RNA sequence. m ⁶A methylation alters gene expression by modulating mRNA processing and metabolism, including alternative splicing, translation efficiency, and stability. Current research shows that m ⁶A methylation is involved in tumorigenesis, highlighting the importance of further study. However, traditional methods are not sensitive enough to detect the full patterns of m ⁶A methylation in the transcriptome. The development of new technologies, such as single-nucleotide detection combined with next generation sequencing, allows for the quick and accurate prediction and identification of m ⁶A methylation sites. In this review, we summarize the recent progress of m ⁶A in tumorigenesis and outline a new direction for both molecular pathology diagnosis and targeted therapy of tumor.

Key words: m ⁶A, RNA methylation, epigenetics, tumor

王天工, 叶孟. m ⁶A甲基化与肿瘤研究进展[J]. 遗传, 2018, 40(12): 1055-1065.

Wang Tiangong, Ye Meng. Advances on the roles of m ⁶A in tumorigenesis[J]. Hereditas(Beijing), 2018, 40(12): 1055-1065.

参考文献

[1]	Dubin DT, Taylor RH . The methylation state of poly A-containing messenger RNA from cultured hamster cells . Nucleic Acids Res, 1975,2(10):1653-1668.
[2]	Lee M, Kim B, Kim VN . Emerging roles of RNA modification: m 6A and U-tail . Cell, 2014,158(5):980-987.
[3]	Wei W, Ji X, Guo X, Ji S . Regulatory Role of N 6- methyladenosine (m 6 A) Methylation in RNA processing and human diseases . J Cell Biochem, 2017,118(9):2534-2543.
[4]	Zhang X, Jia GF . RNA epigenetic modification: N 6- methyladenosine. Hereditas(Beijing) , 2016,38(4):275-288.
[4]	张笑, 贾桂芳 . RNA表观遗传修饰:N 6-甲基腺嘌呤 . 遗传, 2016,38(4):275-288.
[5]	Li YL, Yu J, Song SH . Recent progresses in RNA N6-methyladenosine research. Hereditas(Beijing), 2013,35(12):1340-1351.
[5]	李语丽, 于军, 宋述慧 . RNA中6-甲基腺嘌呤的研究进展. 遗传, 2013,35(12):1340-1351.
[6]	Visvanathan A , Somasundaram K.mRNA traffic gontrol reviewed: N6-Methyladenosine (m 6 A) takes the driver's seat . Bioessays, 2018,40(1). doi: 10.1002/bies.201700093.
[7]	Jacob R, Zander S , Gutschner T. The Dark side of the epitranscriptome: chemical modifications in long non- coding RNAs . Int J Mol Sci, 2017, 18(11): pii: E2387.
[8]	Alarcón CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF . N6-methyladenosine marks primary microRNAs for processing . Nature, 2015,519(7544):482-485.
[9]	Berulava T, Rahmann S, Rademacher K, Klein-Hitpass L, Horsthemke B , N6-adenosine methylation in MiRNAs . PLoS One, 2015,10(2):e0118438.
[10]	Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM . Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase . RNA, 1997,3(11):1233-1247.
[11]	Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC . N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells . Nat Cell Biol, 2014,16(2):191-198.
[12]	Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ , S Adhikari,Shi Y, Lv Y, Chen YS, Zhao X, Li A, Yang Y, U Dahal, Lou XM, Liu X, Huang J, Yuan WP, Zhu XF, Cheng T, Zhao YL, Wang X, Rendtlew Danielsen JM, Liu F, Yang YG. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase . Cell Res, 2014,24(2):177-189.
[13]	Horiuchi K, Kawamura T, Iwanari H, Ohashi R, Naito M, Kodama T, Hamakubo T . Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle . J Biol Chem, 2013,288(46):292-302.
[14]	Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M , Jaffrey SR.m 6A RNA methylation promotes XIST-mediated transcriptional repression . Nature, 2016,537(7620):369-373.
[15]	Pendleton, KE, Chen BLiu KHunter OVXie YTu BP, Conrad NK.The U6 snRNA m 6A methyltransferase METTL16 regulates SAM synthetase intron retention . Cell, 2017,169(5):824-835 e14.
[16]	Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N, Cacchiarelli D, Sanjana NE, Freinkman E, Pacold ME, Satija R, Mikkelsen TS, Hacohen N, Zhang F, Carr SA, Lander ES, Regev A . Perturbation of m 6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites . Cell Rep, 2014,8(1):284-296.
[17]	Huang Y, Yan J, Li Q, Li J, Gong S, Zhou H, Gan J, Jiang H, Jia GF, Luo C, Yang CG . Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5 . Nucleic Acids Res, 2015,43(1):373-384.
[18]	Meyer KD, Jaffrey SR . Rethinking m 6A aeaders, writers, and erasers . Annu Rev Cell Dev Biol, 2017,33:319-342.
[19]	Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, Ren B, Pan T, He C . N6-methyladenosine-dependent regulation of messenger RNA stability. Nature, 2014,505(7481):117-120.
[20]	Alarcon CR , H Goodarzi, Lee H, Liu X, S Tavazoie, SF Tavazoie. HNRNPA2B1 is a mediator of m 6A-dependent nuclear RNA processing events. Cell, 2015. 162(6):1299-1308.
[21]	Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T . N(6)- methyladenosine-dependent RNA structural switches regulate RNA-protein interactions . Nature, 2015,518(7540):560-564.
[22]	Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, Pestova TV, Qian SB, Jaffrey SR . 5' UTR m 6A promotes cap-independent translation . Cell, 2015,163(4):999-1010.
[23]	Li A, Chen YS, Ping XL, Yang X, Xiao W, Yang Y, Sun HY, Zhu Q, Baidya P, Wang X, Bhattarai DP, Zhao YL, Sun BF, Yang YG . Cytoplasmic m 6A reader YTHDF3 promotes mRNA translation . Cell Res, 2017,27(3):444-447.
[24]	Wang X, Zhao BS, Roundtree IR, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C . N(6)-methyladenosine modulates messenger RNA translation efficiency . Cell, 2015,161(6):1388-1399.
[25]	Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB . Dynamic m 6A mRNA methylation directs translational control of heat shock response . Nature, 2015,526(7574):591-594.
[26]	Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, Wang X, Ma HL, Huang CM, Yang Y, Huang N, Jiang GB, Wang HL, Zhou Q, Wang XJ, Zhao YL, Yang YG . Nuclear m 6A reader YTHDC1 regulates mRNA splicing . Mol Cell, 2016,61(4):507-519.
[27]	Wintermeyer W, Zachau HG . A specific chemical chain scission of tRNA at 7-methylguanosine. FEBS Lett, 1970,11(3):160-164.
[28]	Bakin A, Ofengand J . Four newly located pseudouridylate residues in Escherichia coli 23S ribosomal RNA are all at the peptidyltransferase center: analysis by the application of a new sequencing technique. Biochemistry, 1993,32(37):9754-9762.
[29]	Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, Sorek R, Rechavi G . Topology of the human and mouse m 6A RNA methylomes revealed by m6A-seq . Nature, 2012,485(7397):201-206.
[30]	Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR . Comprehensive analysis of mRNA methylation reveals enrichment in 3° UTRs and near stop codons. Cell, 2012,149(7):1635-1646.
[31]	Mauer J, Luo X, Blanjoie A, Jiao X, Grozhik AG, Patil DP, Linder B, Pickering BF, Vasseur JJ, Chen Q, Gross SS, Elemento O, Debart F, Kiledjian M, Jaffrey SR . Reversible methylation of m 6Am in the 5° cap controls mRNA stability . Nature, 2017,541(7637):371-375.
[32]	Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR . Single-nucleotide-resolution mapping of m 6A and m 6Am throughout the transcriptome . Nat Methods, 2015,12(8):767-772.
[33]	Chen K, Lu Z, Wang X, Fu Y, Luo GZ, Liu N, Han D, Dominissini D. Dai Q, Pan T, He C . High-resolution N 6 -methyladenosine (m 6A) map using photo-crosslinking- assisted m 6 A sequencing. Angew Chem Int Ed Engl , 2015,54(5):1587-1590.
[34]	Ke S, Alemu EA, Mertens C, Gantman EC, Fak JJ, Mele A, Haripal B, Zucker-Scharff I, Moore MJ, Park CY, Vågbø CB, Kus?nierczyk A, Klungland A, Darnell JE Jr, Darnell RB . A majority of m 6A residues are in the last exons, allowing the potential for 3° UTR regulation . Genes Dev, 2015,29(19):2037-2053.
[35]	Molinie B, Wang JK, Lim KS, Hillebrand R, Lu ZX, Van Wittenberghe N, Howard BD, Daneshvar K, Mullen AC, Dedon P, Xing Y , Giallourakis CC.m 6A-LAIC-seq reveals the census and complexity of the m 6A epitranscriptome . Nat Methods, 2016,13(8):692-698.
[36]	Liu N, Parisien M, Dai Q, Zheng G, He C, Pan T . Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA . RNA, 2013,19(12):1848-1856.
[37]	Li X, Zhu P, Ma S, Song J, Bai J, Sun F, Yi C . Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat Chem Biol, 2015,11(8):592-597.
[38]	Golovina AY, Dzama MM, Petriukov KS, Zatsepin TS, Sergiev PV, Bogdanov AA, Dontsova OA . Method for site-specific detection of m 6A nucleoside presence in RNA based on high-resolution melting (HRM) analysis . Nucleic Acids Res, 2014,42(4):e27.
[39]	Zhang YC, Zhang SW, Liu L, Liu H, Zhang L, Cui X, Huang Y, Meng J . Spatially enhanced differential RNA methylation analysis from affinity-based sequencing data with hidden markov model . Biomed Res Int, 2015,2015:852070.
[40]	Liu Z., Xiao X, Yu DJ, Jia J, Qiu WR , Chou KC.pRNAm-PC: Predicting N(6)-methyladenosine sites in RNA sequences via physical-chemical properties. Anal Biochem, 2016,497:60-67.
[41]	Chen W, Feng P, Ding H, Lin H , Chou KC.iRNA-Methyl: Identifying N(6)-methyladenosine sites using pseudo nucleotide composition. Anal Biochem, 2015,490:26-33.
[42]	Jia CZ, Zhang JJ, Gu WZ . RNA-MethylPred: A high- accuracy predictor to identify N 6-methyladenosine in RNA. Anal Biochem , 2016,510:72-75.
[43]	Li GQ, Liu Z, Shen HB, Yu DJ . TargetM6A: Identifying N 6-Methyladenosine sites from RNA sequences via position- specific nucleotide propensities and a support vector machine. IEEE Trans Nanobioscience , 2016,15(7):674-682.
[44]	Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q . SRAMP: prediction of mammalian N 6-methyladenosine (m 6A) sites based on sequence-derived features. Nucleic Acids Res , 2016,44(10):e91.
[45]	Xuan JJ, Sun WJ, Lin PH, Zhou KR, Liu S, Zheng LL, Qu LH, Yang JH . RMBase v2.0: deciphering the map of RNA modifications from epitranscriptome sequencing data. Nucleic Acids Res, 2018,46(D1):D327-D334.
[46]	张春霞, 刘峰 . m 6A甲基化修饰调控造血干细胞命运决定 . 遗传, 2017,39(9):863-864.
[47]	Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millán- Zambrano G, Robson SC, Aspris D, Migliori V, Bannister AJ, Han N, De Braekeleer E, Ponstingl H, Hendrick A, Vakoc CR, Vassiliou GS, Kouzarides T . Promoter-bound METTL3 maintains myeloid leukaemia by m 6A-dependent translation control . Nature, 2017,552(7683):126-131.
[48]	Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y , MacKay M,Schulman J, Famulare C, Patel M, Klimek VM, Garrett- Bakelman FE, Melnick A, Carroll M, Mason CE, Jaffrey SR, Kharas MG. The N 6-methyladenosine (m 6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med , 2017,23(11):1369-1376.
[49]	Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C, Sheng Y, Wang Y, Wunderlich M, Zhang B, Dore LC, Su R, Deng X, Ferchen K, Li C, Sun M, Lu Z, Jiang X, Marcucci G, Mulloy JC, Yang J, Qian Z, Wei M, He C, Chen J . METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m 6A modification . Cell Stem Cell, 2018,22(2):191-205.
[50]	Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM . RNA N6-methyladenosine methyltransferase- like 3 promotes liver cancer progression through YTHDF2- dependent posttranscriptional silencing of SOCS2. Hepatology, 2017,67(6):2254-2270.
[51]	Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, Qin X, Tang L, Wang Y, Hong GM, Huang H, Wang X, Chen P, Gurbuxani S, Arnovitz S, Li Y, Li S, Strong J, Neilly MB, Larson RA, Jiang X, Zhang P, Jin J, He C, Chen J . FTO plays an oncogenic role in acute myeloid leukemia as a N 6-methyladenosine RNA demethylase . Cancer Cell, 2017,31(1):127-141.
[52]	Zhou S, Bai ZL, Xia D, Zhao ZJ, Zhao R, Wang YY, Zhe H . FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation. Mol Carcinog, 2018,57(5):590-597.
[53]	Wang X, Li Z, Kong B, Song C, Cong J, Hou J, Wang S . Reduced m 6A mRNA methylation is correlated with the progression of human cervical cancer . Oncotarget, 2017,8(58):98918-98930.
[54]	Nishizawa Y, Konno M, Asai A, Koseki J, Kawamoto K, Miyoshi N, Takahashi H, Nishida N, Haraguchi N, Sakai D, Kudo T, Hata T, Matsuda C, Mizushima T, Satoh T, Doki Y, Mori M, Ishii H . Oncogene c-Myc promotes epitranscriptome m 6A reader YTHDF1 expression in colorectal cancer . Oncotarget, 2018,9(7):7476-7486.
[55]	Yang Z, Li J, Feng G, Gao S, Wang Y, Zhang S, Liu Y, Ye L, Li Y, Zhang X . MicroRNA-145 modulates N 6- methyladenosine levels by targeting the 3'-untranslated mRNA region of the N 6-methyladenosine binding YTH domain family 2 protein. J Biol Chem , 2017,292(9):3614-3623.
[56]	Zhao X, Chen Y, Mao Q, Jiang X, Jiang W, Chen J, Xu W, Zhong L, Sun X . Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Biomark, 2018,21(4):859-868.
[57]	Zhang C, Zhi WI, Lu H, Samanta D, Chen I, Gabrielson E, Semenza GL . Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5- mediated modulation of RNA methylation in breast cancer cells. Oncotarget, 2016,7(40):64527-64542.
[58]	Taketo K, Konno M, Asai A, Koseki J, Toratani M, Satoh T, Doki Y, Mori M, Ishii H, Ogawa K . The epitranscriptome m 6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells . Int J Oncol, 2018,52(2):621-629.
[59]	Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, Sun G, Lu Z, Huang Y, Yang CG, Riggs AD, He C , Shi Y.m 6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells . Cell Rep, 2017,18(11):2622-2634.
[60]	Lai W, Jia J, Yan B, Jiang Y, Shi Y, Chen L, Mao C, Liu X, Tang H, Gao M, Cao Y, Liu S, Tao Y . Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing. Oncotarget, 2018,9(1):901-914.
[61]	Chen B, Ye F, Yu L, Jia G, Huang X, Zhang X, Peng S, Chen K, Wang M, Gong S, Zhang R, Yin J, Li H, Yang Y, Liu H, Zhang J, Zhang H, Zhang A, Jiang H, Luo C, Yang CG . Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc, 2012,134(43):17963-17971.
[62]	McMurray F, Demetriades M, Aik W, Merkestein M, Kramer H, Andrew DS, Scudamore CL, Hough TA, Wells S, Ashcroft FM, McDonough MA, Schofield CJ, Cox RD . Pharmacological inhibition of FTO . PLoS One, 2015,10(4):e0121829.
[63]	Xu C, Liu K, Tempel W, Demetriades M, Aik W, Schofield CJ, Min J . Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation. J Biol Chem, 2014,289(25):17299-17311.
[64]	He W, Zhou B, Liu W, Zhang M, Shen Z, Han Z, Jiang Q, Yang Q, Song C, Wang R, Niu T, Han S, Zhang L, Wu J, Guo F, Zhao R, Yu W, Chai J, Chang J . Identification of a novel small-molecule binding site of the fat mass and obesity associated protein (FTO). J Med Chem, 2015,58(18):7341-7348.
[65]	Qiao Y, Zhou B, Zhang M, Liu W, Han Z. Song C, Yu W, Yang Q, Wang R, Wang S, Shi S, Zhao R, Chai J, Chang J . A novel inhibitor of the obesity-related protein FTO. Biochemistry, 2016,55(10):1516-1522.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

m ⁶A甲基化与肿瘤研究进展

Advances on the roles of m ⁶A in tumorigenesis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	刘传明,丁利军,李佳音,戴建武,孙海翔. 衰老导致卵巢功能低下研究进展[J]. 遗传, 2019, 41(9): 816-826.
[2]	张競文,续倩,李国亮. 癌症发生发展中的表观遗传学研究[J]. 遗传, 2019, 41(7): 567-581.
[3]	马志鹏, 陈军. 无义突变与“遗传补偿效应”[J]. 遗传, 2019, 41(5): 359-364.
[4]	程香荣,胡兴琳,姜琦,黄星卫,王楠,雷蕾. 核糖体DNA转录的表观调控与肿瘤发生[J]. 遗传, 2019, 41(3): 185-192.
[5]	李鑫,李梦玮,张依楠,徐寒梅. 常用肿瘤基因分析方法及基于TCGA数据库的分析应用[J]. 遗传, 2019, 41(3): 234-242.
[6]	吴保军,王卓,董宇,邓宇亮,施奇惠. 肺癌恶性胸腔积液中稀有肿瘤细胞的鉴定与单细胞测序分析[J]. 遗传, 2019, 41(2): 175-184.
[7]	朱亚男, 敖英, 李斌, 万阳, 汪晖. 足细胞发育异常及相关肾脏疾病研究进展[J]. 遗传, 2018, 40(2): 116-125.
[8]	黎伟, 秦俊, 汪晖, 陈廖斌. 表观遗传生物标志物在人类疾病早期诊治中的研究进展[J]. 遗传, 2018, 40(2): 104-115.
[9]	柯玉文,刘江. 动物早期胚胎发育中染色质结构的继承和重编程[J]. 遗传, 2018, 40(11): 977-987.
[10]	杨莹,陈宇晟,孙宝发,杨运桂. RNA甲基化修饰调控和规律[J]. 遗传, 2018, 40(11): 964-976.
[11]	吉新彦, 钟国轩, 赵斌. 哺乳动物Hippo信号通路分子机制研究进展[J]. 遗传, 2017, 39(7): 546-567.
[12]	鲁有望,王昆华. 结直肠癌原发与配对转移肿瘤遗传异质性研究进展[J]. 遗传, 2017, 39(6): 482-490.
[13]	叶仲杰,刘启鹏,岑山,李晓宇. LINE-1编码的逆转录酶在肿瘤形成过程中的作用[J]. 遗传, 2017, 39(5): 368-376.
[14]	刘福林, 周瑾, 张蔚, 汪晖. 胎盘发育过程中的表观遗传学改变及其相关疾病[J]. 遗传, 2017, 39(4): 263-275.
[15]	陈青云,李有志,樊宪伟. 植物气孔发育的分子调控机制[J]. 遗传, 2017, 39(4): 302-312.